| abstract |
A modified double-stranded RNA (cDNA) or short interfering RNA (siRNA) that interacts with a hepatitis C virus (HCV) ribonucleotide target sequence, hepatitis A virus, hepatitis B virus, hepatitis D virus or virus of hepatitis E, where said dsRNA or siRNA binds to cholesterol, in conjunction with a cholesterol reducing drug that is a statin, resin, gemfibrozil or clofibrate, for use in a therapeutic method to inactivate the virus. |